COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,731 Articles (22,502 medRxiv, 8,229 bioRxiv)

Most recent first Previous |  Page 3031: Articles 30301-30310  | Next

Substrate specificity profiling of SARS-CoV-2 Mpro protease provides basis for anti-COVID-19 drug design
Rut, W., Groborz, K., Zhang, L., Sun, X., Zmudzinski, M., Hilgenfeld, R., Drag, M.
10.1101/2020.03.07.981928 — Posted: 2020-03-08 Discussion: Onsite
AI-aided design of novel targeted covalent inhibitors against SARS-CoV-2
Tang, B., He, F., Liu, D., Fang, M., Wu, Z., Xu, D.
10.1101/2020.03.03.972133 — Posted: 2020-03-08
Appealing for Efficient, Well Organized Clinical Trials on COVID-19
Zhao, Y., Wei, Y., Shen, S., Zhang, M., Chen, F.
10.1101/2020.03.05.20031476 — Posted: 2020-03-07
Genome-wide data inferring the evolution and population demography of the novel pneumonia coronavirus (SARS-CoV-2)
Shu, Y.
10.1101/2020.03.04.976662 — Posted: 2020-03-07 Discussion: Onsite
Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites
Chen, S., Kang, S., Yang, M., Hong, Z., Zhang, L., Huang, Z., Chen, X., He, S., Zhou, Z., Zhou, Z., Chen, Q., Yan, Y., Zhang, C., Shan, H.
10.1101/2020.03.06.977876 — Posted: 2020-03-07
Monoclonal antibodies for the S2 subunit of spike of SARS-CoV cross-react with the newly-emerged SARS-CoV-2
Zheng, Z., Monteil, V. M., Maurer-Stroh, S., Yew, C. W., Leong, C., Mohd-Ismail, N. K., Arularasu, S. C., Chow, V. T. K., Lin, R. T. P., Mirazimi, A., Hong, W., Tan, Y.-J.
10.1101/2020.03.06.980037 — Posted: 2020-03-07 Discussion: Onsite
LY6E impairs coronavirus fusion and confers immune control of viral disease
Pfaender, S., Mar, K. B., Michailidis, E., Kratzel, A., Hirt, D., V'kovski, P., Fan, W., Ebert, N., Stalder, H., Kleine-Weber, H., Hoffmann, M., Hoffmann, H. H., Saeed, M., Dijkman, R., Steinmann, E., Wight-Carter, M., Hanners, N. W., Pohlmann, S., Gallagher, T., Todt, D., Zimmer, G., Rice, C. M., Schoggins, J. W., Thiel, V.
10.1101/2020.03.05.979260 — Posted: 2020-03-07 Discussion: Onsite
Novel Immunoglobulin Domain Proteins Provide Insights into Evolution and Pathogenesis Mechanisms of SARS-Related Coronaviruses
Tan, Y., Schneider, T., Leong, M., Aravind, L., Zhang, D.
10.1101/2020.03.04.977736 — Posted: 2020-03-07
Cryo-electron microscopy structure of the SADS-CoV spike glycoprotein provides insights into an evolution of unique coronavirus spike proteins
Ouyang, S.
10.1101/2020.03.04.976258 — Posted: 2020-03-07 Discussion: Offsite
In silico study of the spike protein from SARS-CoV-2 interaction with ACE2: similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism
Othman, H., Bouslama, Z., Brandenburg, J.-T., da Rocha, J., Hamdi, Y., Ghedira, K., Abid, N.-S., Hazelhurst, S.
10.1101/2020.03.04.976027 — Posted: 2020-03-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).